What does the Glucagon Stimulation Test for C-Peptide include?
Metropolis Healthcare measures baseline and post-glucagon C-peptide levels to assess pancreatic insulin-producing capacity.
How does Metropolis Healthcare perform this test?
A blood sample is collected before and after glucagon administration, and C-peptide is analyzed using advanced immunoassay systems.
Who should take this test?
Individuals with diabetes, suspected beta-cell dysfunction, or those being evaluated for insulin therapy suitability may undergo this test at Metropolis Healthcare.
Why is this test useful?
It helps determine endogenous insulin reserve, guiding treatment decisions using Metropolis Healthcare’s accurate testing approach.
Do I need to fast before the test?
Yes, fasting is generally required, and Metropolis Healthcare will provide detailed preparation instructions.
What sample is required?
Serum samples collected at multiple intervals are analyzed at Metropolis Healthcare for C-peptide estimation.
Is glucagon administered during the test?
Yes, glucagon is given under clinical supervision to stimulate C-peptide release, and Metropolis Healthcare ensures proper protocol adherence.
How soon will I receive the results?
Results are typically available within the standard reporting timeline followed by Metropolis Healthcare.